BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Radiopharmaceuticals
    • Science '22 in Review
    • Top Biopharma Trends of 2022
    • Top Med-tech Trends of 2022
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • sign in
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, September 22, 2023
Home » Topics » Regulatory

Regulatory
Regulatory RSS Feed RSS

Philippines is the first market for lamivudine as anti-HBV agent

Dec. 14, 1998
No Comments

Schering-Plough files NDA for next-generation corticosteroid

Dec. 14, 1998
No Comments

FDA approves Rebetron combination therapy for previously untreated HCV patients

Dec. 11, 1998
No Comments

FDA approves Sandostatin LAR once-monthly depot formulation

Dec. 7, 1998
No Comments

Canadian approval obtained for Serostim

Dec. 4, 1998
No Comments

FDA approves Hycamtin as second-line treatment of small cell lung cancer

Dec. 4, 1998
No Comments

FDA approves Verelan PM; launch scheduled for early 1999

Dec. 4, 1998
No Comments

Genzyme General receives FDA approval for Thyrogen

Dec. 3, 1998
No Comments

U.K. approval for new controlled-release nifedipine based on TIMERx technology

Dec. 2, 1998
No Comments

FDA approves new indications, dosing regimens for Vantin

Dec. 2, 1998
No Comments
Previous 1 2 … 931 932 933 934 935 936 937 938 939 … 1028 1029 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Sept. 21, 2023.
  • Myelin sheath and neurons in the brain

    Myelin damaged by multiple sclerosis could be repaired by reducing levels of an enzyme

    BioWorld Science
    In multiple sclerosis (MS), macrophages and microglia play a dual role that could be used to treat this neurodegenerative disease. These cells promote...
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for September 21, 2023.
  • Hands holding torn contract

    Quite a fix: Orthofix sacks three top execs

    BioWorld MedTech
    Orthofix Medical Inc. terminated its CEO, chief financial officer and chief legal officer in a move that plunged the stock from $18.63 at Monday’s close to $13.01...
  • Financial chart and flag of China

    Challenges in China spell trouble for Illumina, 10x and others

    BioWorld MedTech

    China’s recovery from its zero-COVID policy has failed to gain the momentum expected, with many experts predicting a slow or even negative growth rate. A slower...

BioFuture ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing